Sponsor Pipeline

Beijing Immupeutics Medicine Technology Limited Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07203898 A Study of IPM514 in Patients With Esophageal Squamous Cell Carcinoma. Esophageal Squamous Cell Carcinoma Not Yet Recruiting
Get alerts when Beijing Immupeutics Medicine Technology Limited's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free